News wire
Drugs and medical devices
Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.
Source check 3 min ago · Newest item 9 hr ago · 1,441 stories this week · 86 of 90 publishers answering · Browse publishers · RSS feed
Filter stories (1)
Saved on this browser
Drugs and medical devices
Tuesday, October 13
What To Know As State 'Neural Data' Privacy Laws Emerge
Dentons Adds K&L Gates Lawyer To Healthcare Practice In DC
Read at Law360 Life Sciences 2 publishers · 2 reports
The Bonus Track Survives; PMA Preemption Cuts the Rest
FDA Releases 2025 CORE-EP Annual Report
Monday, October 12
Breast Mesh Lawsuits and Internal Bra Complications
Presumption Against Preemption News, Including a Circuit Split
Friday, October 9
TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M
'A Moral Hazard': Kalshi Drug Trial Bets Spark Ethical Qualms
Squires Grants 4 PTAB Petitions, Rejects 3 In New Drop
STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug
Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects
Greenberg Traurig Adds Atty Who Joined Steptoe In February
Arbitration and Genetic Testing
Early Alert: Diagnostic Ultrasound System Issue from Philips Ultrasound
A software app or transducer connection problem with the Philips Lumify diagnostic ultrasound system can result in loss of or delays in scanning functionality.
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hematopoietic cell enrichment kit. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing…
Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use
The Food and Drug Administration (FDA) is classifying the infant pulse rate and oxygen saturation monitor for over-the-counter use into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the infant pulse rate and oxygen saturation monitor for over-the-counter use. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also…
Thursday, October 8
Texas Clinics Settle False COVID-19 Billing Claims For $20M
Judge Tosses Moderna Investor's RSV Vaccine Efficacy Suit
Boston Scientific Brings Heart Puncture Patent Suit
Read at Law360 Life Sciences 2 publishers · 2 reports
US Atty Video Lets Harvard Researcher Probe Motive
USPTO Plan To Limit AIA Reviews Is In White House's Hands
Viatris To Buy Pacira BioSciences For $1.65B
IDScan Data Breach Puts Spotlight On Vendor Oversight
FDA Expects Mifepristone Safety Review Results By March
DLA Piper Taps Two O'Melveny Lawyers For Leadership Roles
Mentalism Makes Me A Better Lawyer
Ex-Thermo Fisher Manager Blames Age, Sex Bias For Ouster
The Medical Device Launch Playbook: Patents, FDA, Reimbursement and Strategic Timing
2nd Circ. Spikes Yale Health Workers' Vax Mandate Challenge
Connect the news to your market.
Research the firms, offices and conference relationships behind the headlines.